Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Lightlake Therapeutics receives funding for development of intranasal naloxone

Aug. 5, 2014

Evzio auto-injector available in the U.S. for emergency treatment of opioid overdose

July 11, 2014

Presentation of data on Aeolus' AEOL-10150 medical countermeasure

July 4, 2014

Embera's phase I study of EMB-001 to receive funding from Sounds Affects Life

July 4, 2014

Japanese researchers present radiation-induced injury treatments

June 27, 2014

Orexo reports phase III data on Zubsolv for induction of buprenorphine maintenance therapy

June 25, 2014

Bunavail buccal film approved by FDA for opioid dependence

June 11, 2014

Pfizer researchers design nicotine vaccines with higher avidity

May 26, 2014

Double-blind trial finds (S)-(-)-OSU-6162 effective in treating alcohol dependence

May 9, 2014

FDA approves Evzio for the emergency treatment of opioid overdose

April 7, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...